SAN MATEO, Calif., Jan. 7, 2021 /PRNewswire/ — Rakuten Medical, Inc. (RMI), a global biotechnology company developing precision-targeted cancer therapies based on its proprietary, anti-cancer treatment platform, Illuminox™, will present at the 39th Annual J.P. Morgan Healthcare Conference being held virtually January 11-14, 2021.

Rakuten Medical’s Chairman and CEO, Hiroshi “Mickey” Mikitani, is scheduled to present virtually at approximately 4:30 a.m. PST, Monday, January 11. A live audio webcast of the presentation can be accessed by following this link.

Read more here… or watch below!